Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Spitzer

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Cancer Immunology Research|October 15, 2024
T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα InflammationNam Woo Cho, Sophia M Guldberg, Barzin Y Nabet, et al.
Head & Neck|June 18, 2026
Metastatic Lymph Node Status Is Associated With Progression-Free Survival in Oral Cavity Squamous Cell Carcinoma Treated With PembrolizumabAngeline A Truong, Savinnie Ho, Minna K I Apostolova, et al.
Nature Biotechnology|August 21, 2019
De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humansTobias Deuse, Xiaomeng Hu, Sean Agbor-Enoh, et al.
Cell Reports|July 27, 2017
Mass Cytometric Analysis of HIV Entry, Replication, and Remodeling in Tissue CD4+ T CellsMarielle Cavrois, Trambak Banerjee, Gourab Mukherjee, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
A conserved immune trajectory of recovery in hospitalized COVID-19 patientsCassandra E Burnett, Trine Line Hauge Okholm, Iliana Tenvooren, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Commensal myeloid crosstalk in neonatal skin regulates long-term cutaneous type 17 inflammationMiqdad O Dhariwala, Andrea M DeRogatis, Joy N Okoro, et al.
Science (New York, N.Y.)|December 15, 2022
Synthetic cytokine circuits that drive T cells into immune-excluded tumorsGreg M Allen, Nicholas W Frankel, Nishith R Reddy, et al.
Immunity|July 2, 2022
Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patientsCassandra E Burnett, Trine Line Hauge Okholm, Iliana Tenvooren, et al.
Clinical Colorectal Cancer|March 13, 2026
Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal CancerAndrea Bocobo, Julia Whitman, Bridget P Keenan, et al.
Cell|June 5, 2020
Intratumoral CD4<sup>+</sup> T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder CancerDavid Y Oh, Serena S Kwek, Siddharth S Raju, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Cancer Immunology Research|October 15, 2024
T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα InflammationNam Woo Cho, Sophia M Guldberg, Barzin Y Nabet, et al.
Head & Neck|June 18, 2026
Metastatic Lymph Node Status Is Associated With Progression-Free Survival in Oral Cavity Squamous Cell Carcinoma Treated With PembrolizumabAngeline A Truong, Savinnie Ho, Minna K I Apostolova, et al.
Nature Biotechnology|August 21, 2019
De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humansTobias Deuse, Xiaomeng Hu, Sean Agbor-Enoh, et al.
Cell Reports|July 27, 2017
Mass Cytometric Analysis of HIV Entry, Replication, and Remodeling in Tissue CD4+ T CellsMarielle Cavrois, Trambak Banerjee, Gourab Mukherjee, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
A conserved immune trajectory of recovery in hospitalized COVID-19 patientsCassandra E Burnett, Trine Line Hauge Okholm, Iliana Tenvooren, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Commensal myeloid crosstalk in neonatal skin regulates long-term cutaneous type 17 inflammationMiqdad O Dhariwala, Andrea M DeRogatis, Joy N Okoro, et al.
Science (New York, N.Y.)|December 15, 2022
Synthetic cytokine circuits that drive T cells into immune-excluded tumorsGreg M Allen, Nicholas W Frankel, Nishith R Reddy, et al.
Immunity|July 2, 2022
Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patientsCassandra E Burnett, Trine Line Hauge Okholm, Iliana Tenvooren, et al.
Clinical Colorectal Cancer|March 13, 2026
Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal CancerAndrea Bocobo, Julia Whitman, Bridget P Keenan, et al.
Cell|June 5, 2020
Intratumoral CD4<sup>+</sup> T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder CancerDavid Y Oh, Serena S Kwek, Siddharth S Raju, et al.
Pageof 16